Annovis Bio's total assets for Q2 2025 were $21.45B, an increase of 80143.00% from the previous quarter. ANVS total liabilities were $3.12B for the fiscal quarter, a 116341.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.